Skip to content
FDA drug shortage status

Is Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (Lidocaine Hydrochloride And Epinephrine) in shortage?

Yes. Epinephrine Bitartrate, Lidocaine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

In shortageFDA status
22packages listed
11unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release December 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 18, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: August 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

FDA recalls of the same active ingredient

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Epinephrine Bitartrate, Lidocaine Hydrochloride Injection:

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage questions

Is Epinephrine Bitartrate, Lidocaine Hydrochloride Injection (Lidocaine Hydrochloride And Epinephrine) in shortage?

Yes. Epinephrine Bitartrate, Lidocaine Hydrochloride Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

Why is there a Epinephrine Bitartrate, Lidocaine Hydrochloride Injection shortage?

FDA records the reason as: Demand increase for the drug; Other.

What should I do if I can’t get Epinephrine Bitartrate, Lidocaine Hydrochloride Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.